Clinical Trial

ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)

Study acronym: ADAPT-AST
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to improve the way urinary tract infections (UTIs) are tested for antibiotic resistance. The main questions it aims to answer are: * Can the investigators use a method called Bayesian causal inference to create or check clinical prediction models that help predict if certain antibiotics will work for a urinary infection, using patient information from the National Health Service (NHS)? * Can this new ADAPT-AST method, which uses data and a smarter approach, do a better job of testing for urinary infection than the old methods? Will it help doctors make quicker decisions and save resources by being more efficient? Participants in this study will not be receiving treatments. The study will involve: Using statistical methods to predict UTI test results based on patient data. Evaluating whether this new approach can provide doctors with more timely and useful information for treating UTIs. Assessing whether it can help save money and resources in the lab and pharmacy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-04; most recent amendment 2025-01-31.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-01-31
Trial Details
NCT Number NCT06297837
Lead Sponsor Liverpool University Hospitals NHS Foundation Trust
Conditions Urinary Tract Infections
Enrollment 500,000 participants
Start Date 2024-09-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-02-04